• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years

Bill Would Require Medicare to Cover New Breakthrough Devices for at Least 4 Years

by Glenn S. Demby | May 4, 2023 | Essential, FDA-lir, Laboratory Industry Report

The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Breakthrough Device Designations Fall 37 Percent in 2022

New Breakthrough Device Designations Fall 37 Percent in 2022

by Glenn S. Demby | Feb 22, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

According to the FDA’s recently-released annual report, only 135 devices received the designation last year, versus 213 in 2021.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Want Breakthrough Device Designation? You’ll Need to Consider Health Equity

Want Breakthrough Device Designation? You’ll Need to Consider Health Equity

by Glenn S. Demby | Nov 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In draft guidance, the FDA is proposing that medical device makers will need to consider how accessible their products are to underserved populations.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA to Consider Health Disparities in Granting Breakthrough Device Designation

FDA to Consider Health Disparities in Granting Breakthrough Device Designation

by Glenn S. Demby | Nov 14, 2022 | News, Open Content

Medical device makers will have to show that their products will be accessible to disadvantaged populations.

FDA Launches Pilot Program to “De-risk the Medical Device Valley of Death”

FDA Launches Pilot Program to “De-risk the Medical Device Valley of Death”

by Rachel Muenz | Oct 12, 2022 | News, Open Content

The CDRH Total Product Life Cycle Advisory Program Pilot aims to improve the FDA authorization process for medical devices.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com